We are live on ! Find out more
VCYT icon

Veracyte

293 hedge funds and large institutions have $2.78B invested in Veracyte in 2024 Q3 according to their latest regulatory filings, with 76 funds opening new positions, 87 increasing their positions, 92 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

911% more call options, than puts

Call options by funds: $4.58M | Put options by funds: $453K

245% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 22

56% more capital invested

Capital invested by funds: $1.78B → $2.78B (+$1B)

22% more funds holding

Funds holding: 240293 (+53)

0.92% less ownership

Funds ownership: 107.44%106.52% (-0.92%)

5% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 92

Holders
293
Holders Change
+53
Holders Change %
+22.08%
% of All Funds
4.21%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
76
Increased
87
Reduced
92
Closed
22
Calls
$4.58M
Puts
$453K
Net Calls
+$4.13M
Net Calls Change
+$3.58M
Name Holding Trade Value Shares
Change
Change in
Stake
AAMU
26
AEGON Asset Management (UK)
United Kingdom
$24.3M -$1.25M -44,402 -6%
Macquarie Group
27
Macquarie Group
Australia
$24.2M +$20M +711,362 New
Morgan Stanley
28
Morgan Stanley
New York
$24.2M +$6.62M +235,207 +49%
EAM
29
Eventide Asset Management
Massachusetts
$23.1M +$3.2M +113,883 +20%
CC
30
Casdin Capital
New York
$22.7M -$5.39M -191,596 -22%
Renaissance Technologies
31
Renaissance Technologies
New York
$20.2M +$4.88M +173,500 +41%
NCGI
32
Next Century Growth Investors
Minnesota
$19.6M +$12M +428,280 +290%
Citadel Advisors
33
Citadel Advisors
Florida
$17M +$12.7M +452,731 +950%
SCM
34
Silverarc Capital Management
Massachusetts
$16M +$5.3M +188,317 +67%
Legal & General Group
35
Legal & General Group
United Kingdom
$15.4M -$4.32M -153,605 -25%
SBH
36
Segall Bryant & Hamill
Illinois
$15.1M +$2M +71,086 +19%
Man Group
37
Man Group
United Kingdom
$14.2M -$7.41M -263,524 -39%
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
$13.8M +$8.76M +311,416 +335%
Jennison Associates
39
Jennison Associates
New York
$13.1M -$438K -15,581 -4%
DCM
40
Driehaus Capital Management
Illinois
$12.3M +$10.2M +362,212 New
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$12.3M +$7.54M +268,000 +289%
JP Morgan Chase
42
JP Morgan Chase
New York
$11.8M -$71.5K -2,543 -0.7%
Millennium Management
43
Millennium Management
New York
$11.4M +$7.63M +271,278 +422%
Invesco
44
Invesco
Georgia
$11M -$2.51M -89,251 -22%
GIM
45
Granahan Investment Management
Massachusetts
$10.6M -$792K -28,166 -8%
Jane Street
46
Jane Street
New York
$10.3M +$6.23M +221,504 +276%
Lord, Abbett & Co
47
Lord, Abbett & Co
New Jersey
$9.5M +$7.85M +279,032 New
Arrowstreet Capital
48
Arrowstreet Capital
Massachusetts
$9.23M +$7.63M +271,248 New
SEI Investments
49
SEI Investments
Pennsylvania
$9.17M +$3.39M +120,614 +81%
CSS
50
Cubist Systematic Strategies
Connecticut
$8.7M +$6.23M +221,498 +653%

VCYT Hedge Fund Activity: Q3 2024 in Review

293 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2024, worth a combined $2.78B — up 56% from $1.78B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new VCYT positions and 22 closed out — a net gain of 54 holders — while 87 added to existing stakes and 92 trimmed.

The largest buyer was Artisan Partners, adding an estimated $55.1M. The largest seller was Wellington Management Group, cutting an estimated $74.4M.

  • 293 institutional investors held Veracyte (VCYT) as of Q3 2024, up from 240 in Q2 2024.
  • Funds reported $2.78B of Veracyte stock for Q3 2024, up 56% quarter-over-quarter.
  • 76 funds opened new Veracyte positions in Q3 2024 and 22 closed out, a net change of +54 holders.
  • The largest Veracyte buyer in Q3 2024 was Artisan Partners, an estimated $55.1M added.
  • The largest Veracyte seller in Q3 2024 was Wellington Management Group, an estimated $74.4M sold.

Based on aggregated 13F filings for Q3 2024.